Intraoperative indocyanine green (ICG) angiography in hemangioblastoma surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00025684

Enrollment

Registered

2021-06-22

Start date

2021-07-04

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

D33.9

Interventions

Group 1: Patients with intraoperative ICG angiography used in hemangioblastoma surgery from August 2018 - February 2021.

Eligibility

Sex/Gender

All

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Intraoperatively used ICG angiography in hemangioblastoma surgery during August 2018 - February 2021.

Exclusion criteria

Exclusion criteria: Intraoperative ICG angiography not used in hemangioblastoma surgery during August 2018 - February 2021.

Design outcomes

Primary

Measure	Time frame
Qualitative evaluation of intraoperative ICG angiography in hemangioblastoma surgery to distinguish tumor-feeding and draining vessels (retrospective review period: August 2018-February 2021).	—

Secondary

Measure	Time frame
Intra-/postoperative complications, duration of surgery, clinical-neurological course postoperatively.	—

Countries

Germany

Contacts

Public ContactJan-Helge Klingler

Universitätsklinikum Freiburg, Klinik für Neurochirurgie

jan-helge.klingler@uniklinik-freiburg.de+49 761 270 50010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026